icone plus
Contact Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Clinical Added Value
no clinical added value
NEVANAC 1 mg/ ml, eye drops, suspension does not offer any improvement in actual benefit (IAB V) over standard management of postoperative macular oedema associated with cataract surgery in diabetic patients.
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
Ln3mBdbmr2wa8JVL
Listen
